N-乙基-3-(4-甲基-1-哌嗪基)-1-丙胺 | 224456-89-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: N-乙基-3-(4-甲基-1-哌嗪基)-1-丙胺
• 中文别名: 2,2,3,3,4,4,4-七氟-N-(2,2,3,3,4,4,4-七氟丁基)-N-亚硝基丁烷-1-胺
• 英文名称: N-ethyl-3-(4-methylpiperazin-1-yl)propan-1-amine
• CAS: 224456-89-7
• 化学式: C₁₀H₂₃N₃
• mdl: MFCD10687347
• 分子量: 185.313
• InChiKey: IVCQNWFWUGMGBJ-UHFFFAOYSA-N

物化性质

• 沸点：
  250.3±8.0 °C(Predicted)
• 密度：
  0.906±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  N-乙基-3-(4-甲基-1-哌嗪基)-1-丙胺 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 三乙胺 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 (2S)-3-(4-chlorophenyl)-N-ethyl-2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-N-[3-(4-methylpiperazin-1-yl)propyl]propanamide
  参考文献：
  名称：

  The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists

  摘要：

  The discovery of a novel series of 8-azabicyclo[3.2.1] octan-3-yl)-3-(4-chlorophenyl) propanamide antagonists of the vasopressin V-1A receptor is disclosed. Compounds 47 and 48 were found to be high affinity, selective vasopressin V-1A antagonists. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.02.096

文献信息

• Anilino-pyrimidine phenyl and benzothiophene analogs
  申请人：Hu Yongbo

  公开号：US20070244140A1

  公开（公告）日：2007-10-18

  The present invention relates to compounds of formula III: wherein R 2 , R 3 , R 5 and R 6 are as defined herein.

  本发明涉及以下式III的化合物： 其中R2、R3、R5和R6如本文所定义。
• CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS D-GLUCORONATE SALTS
  申请人：Mirmehrabi Mahmoud

  公开号：US20080262010A1

  公开（公告）日：2008-10-23

  The present invention relates to methods for preparing one or more crystalline polymorphs of a compound of formula I: and structurally related compounds. The present invention is also directed to methods for converting one polymorph to other different polymorphs of formula I and structurally related compounds.

  本发明涉及制备化合物I的一个或多个结晶多型的方法，以及与结构相关的化合物。本发明还涉及将一个多型转化为化合物I的其他不同多型的方法，以及与结构相关的化合物。
• CRYSTALLINE FORMS AND POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS SUCCINATE SALTS
  申请人：Mirmehrabi Mahmoud

  公开号：US20080262008A1

  公开（公告）日：2008-10-23

  The present invention relates to methods for preparing and manufacturing a crystalline form or polymorph of a compound of formula I: in the form of pharmaceutically acceptable salts and polymorphs thereof. The present invention is directed to methods for preparing and manufacturing crystalline polymorphs or forms of specific anilino-pyrimidine benzenesulfonamide compounds. Methods for converting one crystalline form or polymorph of compounds of formula I as their pharmaceutically acceptable salt polymorph to other different crystalline polymorphs of compounds of formula I as their corresponding pharmaceutically acceptable salt are also disclosed.

  本发明涉及制备和制造化合物I的结晶形式或多型的方法：以药学上可接受的盐和多型的形式。本发明涉及制备和制造特定苯磺酰胺基吡啶类化合物的结晶多型或形式的方法。还揭示了将化合物I的一种结晶形式或多型转化为其他不同的化合物I的结晶多型，作为相应的药学上可接受的盐的方法。
• Indenoisoquinolinone analogs and methods of use thereof
  申请人：Jagtap Prakash

  公开号：US20070049555A1

  公开（公告）日：2007-03-01

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病、肾病、神经病、勃起功能障碍或尿失禁的方法，包括向需要治疗的受体内给予有效量的Indenoisoquinolinone类似物。
• CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS ACETATE SALTS
  申请人：Mirmehrabi Mahmoud

  公开号：US20080262009A1

  公开（公告）日：2008-10-23

  The present invention relates to methods for preparing one or more crystalline forms and polymorphs of a compound of formula I: and structurally related compounds. The present invention is also directed to methods for converting one polymorph to other different polymorphs of formula I and structurally related compounds.

  本发明涉及制备一种或多种化合物I的晶体形式和多晶形式的方法，以及与化合物I结构相关的化合物。本发明还涉及将一种多晶形式转化为化合物I和结构相关化合物的其他不同多晶形式的方法。